We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVP icon
3151
Retractable Technologies
RVP
$20.1M
$43K ﹤0.01%
3,725
+379
+11% +$3.99K
SCS
3152
DELISTED
Steelcase
SCS
$43K ﹤0.01%
2,825
-5,377
-66% -$77.5K
UEIC icon
3153
Universal Electronics
UEIC
$74.1M
$43K ﹤0.01%
894
-1,523
-63% -$79K
KLRS
3154
Kalaris Therapeutics
KLRS
$96.8M
$43K ﹤0.01%
95
+23
+32% +$11.9K
TVRD
3155
Tvardi Therapeutics
TVRD
$22.4M
$43K ﹤0.01%
83
-26
-24% -$16.5K
SCPL
3156
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$43K ﹤0.01%
2,552
+815
+47% +$14K
ATNX
3157
DELISTED
Athenex, Inc. Common Stock
ATNX
$43K ﹤0.01%
460
-2,206
-83% -$201K
VIVO
3158
DELISTED
Meridian Bioscience Inc
VIVO
$43K ﹤0.01%
1,934
-5,468
-74% -$116K
HNGR
3159
DELISTED
Hanger Inc.
HNGR
$43K ﹤0.01%
1,674
-20
-1% -$499
CALA
3160
DELISTED
Calithera Biosciences, Inc
CALA
$43K ﹤0.01%
1,031
+78
+8% +$3.43K
APYX icon
3161
Apyx Medical
APYX
$144M
$42K ﹤0.01%
4,093
+2,165
+112% +$21.5K
ARMK icon
3162
Aramark
ARMK
$15.8B
$42K ﹤0.01%
1,579
-39,626
-96% -$1.09M
BATRK icon
3163
Atlanta Braves Holdings Series B
BATRK
$3.24B
$42K ﹤0.01%
1,509
-690
-31% -$18.9K
BFC icon
3164
Bank First Corp
BFC
$1.71B
$42K ﹤0.01%
606
+269
+80% +$19.2K
CNVS icon
3165
Cineverse
CNVS
$64.9M
$42K ﹤0.01%
1,656
+1,626
+5,420% +$44.9K
DDM icon
3166
ProShares Ultra Dow30
DDM
$548M
$42K ﹤0.01%
1,156
-540
-32% -$19K
DEM icon
3167
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
$42K ﹤0.01%
924
+594
+180% +$27.2K
DSGN icon
3168
Design Therapeutics
DSGN
$896M
$42K ﹤0.01%
2,129
+1,731
+435% +$43.7K
DMC
3169
Del Monte Corp
DMC
$1.44B
$42K ﹤0.01%
1,286
-7,571
-85% -$244K
GRBK icon
3170
Green Brick Partners
GRBK
$3.06B
$42K ﹤0.01%
1,874
-5,267
-74% -$126K
HYFM icon
3171
Hydrofarm Holdings
HYFM
$8.77M
$42K ﹤0.01%
72
+20
+38% +$11.8K
IWC icon
3172
iShares Micro-Cap ETF
IWC
$1.5B
$42K ﹤0.01%
278
-19,158
-99% -$2.84M
JOE icon
3173
St. Joe Company
JOE
$3.84B
$42K ﹤0.01%
952
-4,150
-81% -$187K
REYN icon
3174
Reynolds Consumer Products
REYN
$5.48B
$42K ﹤0.01%
1,379
-2,769
-67% -$84K
AVID
3175
DELISTED
Avid Technology Inc
AVID
$42K ﹤0.01%
1,071
-2,835
-73% -$81.4K
125 126
127
128 129

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.